Geron Corporation (GERN) vs Lexicon Pharmaceuticals, Inc. (LXRX)
Geron Corporation and Lexicon Pharmaceuticals, Inc. are both Biotechnology companies. Geron Corporation and Lexicon Pharmaceuticals, Inc. are of similar size ($854.3M and $815.9M). Geron Corporation grew revenue faster over the last twelve months: 24.4% against −29.0%. Geron Corporation has the higher net margin (−33.1% vs −147.4%) and the higher return on invested capital (−89.9% vs −96.4%). Across the 18 metrics below, Geron Corporation leads on 12 and Lexicon Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | GERN | LXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.51% | 99.14% | 65.16% |
| Operating margin | (25.31%) | (131.43%) | 0.00% |
| Net margin | (33.05%) | (147.38%) | 0.00% |
| Free cash flow margin | (56.10%) | (156.71%) | 0.00% |
| Return on equity | (28.28%) | (40.21%) | (57.72%) |
| Return on assets | (12.59%) | (25.70%) | (49.22%) |
| Return on invested capital | (89.85%) | (96.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack